PharmiWeb.com - Global Pharma News & Resources

Press Releases

Date Title Company
17-Feb-2026 Harmony Biosciences Receives U.S. Food and Drug Administration Approval for WAKIX® (pitolisant) for the Treatment of Cataplexy in Pediatric Narcolepsy Businesswire
17-Feb-2026 Alcon Launches TOTAL30 Multifocal for Astigmatism, the World’s Only Monthly Multifocal Toric Contact Lens with Water Gradient Technology Businesswire
17-Feb-2026 BIOEMTECH and NorthStar Medical Radioisotopes Announce Strategic Supply Agreement for Actinium-225 to Support Preclinical Radiopharmaceutical Research Businesswire
17-Feb-2026 Clinical Utility of bioAffinity Technologies’ CyPath® Lung Test Demonstrated in Real-World Case Study Businesswire
17-Feb-2026 Revvity to Present at Upcoming Investor Conferences Businesswire
17-Feb-2026 Rallybio Announces Positive Data for RLYB116 Phase 1 Study Demonstrating Complete and Sustained Inhibition of Terminal Complement Businesswire
17-Feb-2026 Ray Therapeutics Appoints Michael Murtagh as Chief Regulatory Officer Businesswire
17-Feb-2026 Artis BioSolutions Appoints Dr. Kate Broderick, Ph.D., as Chief Scientific Innovation Officer to Advance Synthetic DNA Strategy Businesswire
17-Feb-2026 Scribe Therapeutics Achieves Second Success Milestone for In Vivo Program in Collaboration with Eli Lilly and Company Businesswire
17-Feb-2026 Turn Therapeutics Appoints Dr. Robert Redfield as Senior Advisor of Health Policy and Regulatory Affairs Businesswire
17-Feb-2026 LUMANITY BECOMES FIRST LIFE SCIENCES VALUE DEMONSTRATION PARTNER TO ACHIEVE ISO 42001 CERTIFICATION, SETTING A NEW STANDARD FOR RESPONSIBLE AI IN LIFE SCIENCES LUMANITY
17-Feb-2026 MRI Artifacts: Head Position Matters KL Krems
17-Feb-2026 Watchmaker Genomics Licenses CRISPR-Cas9 Intellectual Property from Caribou Biosciences to Increase Throughput and Reduce Sequencing Cost per Sample Watchmaker Genomics
17-Feb-2026 NeoGenomics Reports Fourth Quarter and Full Year 2025 Results Businesswire
17-Feb-2026 Deciphera Pharmaceuticals Announces U.S. Food and Drug Administration Acceptance for Filing of New Drug Application for Tirabrutinib in Patients with Relapsed or Refractory PCNSL Businesswire
17-Feb-2026 Satellos to Participate in Upcoming Investor Conferences Businesswire
17-Feb-2026 NationsBenefits and Kinney Drugs Partner to Expand Flex Card Access for Rx and OTC Health Needs in New York Businesswire
17-Feb-2026 U.S. Food and Drug Administration Accepts Bristol Myers Squibb's New Drug Application for Iberdomide in Patients with Relapsed or Refractory Multiple Myeloma Businesswire
17-Feb-2026 Pfizer’s BRAFTOVI Regimen Improves Progression-Free Survival in Metastatic Colorectal Cancer Businesswire
17-Feb-2026 Watchmaker Genomics Licenses CRISPR-Cas9 Intellectual Property from Caribou Biosciences to Increase Throughput and Reduce Sequencing Cost per Sample Watchmaker Genomics